Evidence for pharmacy innovation

摘要

I read with interest the comments by Andy Murdock and others quoted in your report of the pharmacy engagement meeting in London (PJ, 8 March, p265). Although prospective studies published in peer-reviewedjournals are undoubtedly the gold standard for evaluating proposed innovations in pharmacy services, they may also be gold-plated. If pharmacy wants to introduce new services, it does not have the benefit of the budget and timescale that the industry has to introduce new drugs. So best use must be made of the evidence we already have.This clearly involves being able to locate properly designed studies in UK conditions where these exist.